Viewing Study NCT02324803


Ignite Creation Date: 2025-12-24 @ 7:23 PM
Ignite Modification Date: 2026-02-24 @ 5:50 AM
Study NCT ID: NCT02324803
Status: UNKNOWN
Last Update Posted: 2014-12-24
First Post: 2014-12-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC Patients
Sponsor: Southern China Urology Cancer Consortium
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module